North American Flexible Endoscopes Market Research Report
- Report Code: FL 1000
- Publish Date: Upcoming
The North American flexible endoscopes market, mainly driven by favorable reimbursements in select geographies, growing aging population, and the increasing prevalence/incidence of diseases requiring endoscopy procedures, was valued at $1.27 billion in 2013, and is expected to reach $1.91 billion by 2018, at a CAGR of 8.5% during the forecast period, 2013 to 2018.
The report analyzes the market of devices by segments such as colonoscope, bronchoscope, upper GI endoscope, laryngoscope, pharyngoscope, deudonoscope, naso-pharyngoscope, and rhinoscope, among others. With a market value of $0.32 billion and $0.26 billion, the colonoscope and upper GI endoscope segments have been contributing 25.2% and 20.3% to the total North American flexible endoscopes market. All these segments experienced a positive growth owing to an increased awareness of patients and physicians towards the usage and reception of new endoscopy technologies, due to the numerous advantages offered by flexible endoscopes devices.
The demand for flexible endoscopes has increased significantly, largely because of patients’ preference for minimally invasive surgeries. Endoscopic procedures are low-risk procedures and are easily covered by health insurance. A pivotal factor that propels the growth of the endoscopy market is the rapid rise in the number of elderly people who are prone to orthopedic, gastrointestinal, and ophthalmic diseases, as well as cancer. As per the World Health Organization (WHO), between 2000 and 2050, the proportion of the world's population that is aged 60 years will double from about 11% to 22%. This aging population is the main end-user of knee-hip implants, bariatric surgeries, gastrointestinal endoscopy, and colonoscopy procedures. With the growing number of elderly people, age-related ailments are also expected to rise sharply, thus propelling the demand and consumption of flexible endoscopes devices concomitantly.
The number of people in the world who are obese or overweight has reached 2.1 billion, from 875 million in 1980. Furthermore, nearly 7 million people in the United States have some symptoms of gastroesophageal reflux disorder (GERD). Primary or secondary GERD diagnosis increased by an unprecedented 216 percent or from a total of 995,402 individuals diagnosed in 1998 to 3,141,965 in 2005. 4.2 percent of all people hospitalized with GERD in 2005 also had an esophageal disorder. In the United States, 1,150 deaths in 2004 were directly related to a primary diagnosis of GERD. Endoscopic treatments for GERD are newer and are still being studied but are likely to grow in the coming years.
The rapidly aging population, increased obesity rates, and the growing incidence of associated disease are some of the major factors driving the North American endoscopy market. The high incidence of colon cancer, combined with the increased reimbursement coverage for colorectal cancer screening, is expected to fuel the demand for endoscopy instruments in this region.
According to Centers for Disease Control and Prevention, 52,045 people in the United States died from colorectal cancer, including 27,073 men and 24,972 women. In 2014, about 136,830 people are predicted to be diagnosed with colorectal cancer in the U.S., and about 50,310 people are predicted to die of the disease. In both men and women, colorectal cancer is the third most commonly diagnosed cancer and the third-leading causer of cancer deaths.
The report also provides an extensive competitive landscaping of the leading companies operating in the flexible endoscopes market. The key players in flexible endoscopes segment are Stryker Corporation, Ethicon Endo-Surgery, Inc, Olympus Corporation, Covidien Plc, Boston Scientific, Arthrex, Inc., Smiths Group, Aesculap, Inc, Karl Storz, ConMed, Richard Wolf GmbH, HOYA CORPORATION and Fujifilm Holdings Corporation. The segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Customization Options:
Along with the market data, customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and a deep dive analysis of the following parameters:
Product Analysis:
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix, which gives a detailed comparison of Flexible Endoscopes product portfolio of each company, mapped at country and sub-segment levels
- End-user adoption rate analysis of products (segment-wise and country-wise)
- A comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data:
- Country-specific prevalence of cancer, gastrointestinal tract disorders, gastroesophageal reflux disorder (GERD), and gynecological disorders
- Country-specific patient pool of cancer, gastrointestinal tract disorders, gastroesophageal reflux disorder (GERD), and gynecological disorders
- Disease progression (pattern analysis)
Procedure Volume Data:
- Different types of flexible endoscopes procedures performed annually in each country, tracked till sub- segment level
- The number of abdominal, gastro intestinal, interior of joints, gynecology, bronchology, and large & small intestinal procedures performed in each country
Surgeons/Physicians Perception Matrix:
- Fast turn-around analysis of surgeons’ responses to market events and trends
- Surgeons’ opinions about products from different companies
- Surgeons’ qualitative inputs on epidemiology date
Pricing Trends:
- Cost analysis of flexible endoscopes devices in the region
- Abdominal, gastro intestinal, interior of joints, gynecology, bronchology, large & small intestinal procedural investment in major countries
Competitive Intelligence
- The company share analysis of the top players of the market in the region
- The crucial developments and strategies that companies inculcate in their portfolio
Perception Matrix:
- A comprehensive study of customers’ perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- An analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Alternative Products: Impact analysis
MMM’s Healthcare Decision Making Quadrant: It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters such patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and cancer centers, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure)
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Endoscopes Market The North American endoscope market was valued at $4.9 billion in 2013 and is expected to reach $6.8 billion by 2018, growing at a CAGR of 6.8% during the forecast period. The key players in this market are Stryker Corporation, Ethicon Endo-Surgery, Inc., Olympus Corporation, Covidien plc, Arthrex, Inc., Smiths Group plc, Aesculap, Inc., ConMed Corporation, Richard Wolf GmbH, Hoya Corporation, and Fujifilm Holdings Corporation. The details of segment and country-specific company shares, news and deals, mergers and acquisitions, segment-specific pipeline products, product approvals, and product recalls of the major companies have also been covered in the report. |
Upcoming |
|
|
European Endoscopes Market The European endoscope market was valued at $3.2 billion in 2013 and is expected to reach $4.2 billion by 2018, growing at a CAGR of 5.7% during the forecast period. The key players in this market are Stryker Corporation, Ethicon Endo-Surgery, Inc., Olympus Corporation, Covidien plc, Arthrex, Inc., Smiths Group plc, Aesculap, Inc., ConMed Corporation, Richard Wolf GmbH, Hoya Corporation, and Fujifilm Holdings Corporation. The details of segment and country-specific company shares, news and deals, mergers and acquisitions, segment-specific pipeline products, product approvals, and product recalls of the major companies have also been covered in the report. |
Upcoming |
|
|
Asian Endoscopes Market The Asian endoscope market was valued at $2.9 billion in 2013 and is expected to reach $4.2 billion by 2018, growing at a CAGR of 7.6% during the forecast period. The key players in this market are Stryker Corporation, Ethicon Endo-Surgery, Inc., Olympus Corporation, Covidien plc, Arthrex, Inc., Smiths Group plc, Aesculap, Inc., ConMed Corporation, Richard Wolf GmbH, Hoya Corporation, and Fujifilm Holdings Corporation. The details of segment and country-specific company shares, news and deals, mergers and acquisitions, segment-specific pipeline products, product approvals, and product recalls of the major companies have also been covered in the report. |
Upcoming |
